Key drivers for the regions include: for North America, investments in research and development, policies supporting the use of endotoxin testing and removal services, and a mature ecosystem; for Europe, demographics with an aging population, infrastructure with established healthcare systems, and regulatory requirements; for Asia Pacific, adoption of new technologies, government initiatives supporting the growth of the pharmaceutical industry, and a large patient population; for Latin America, increasing awareness of endotoxin testing and removal services, expanding healthcare infrastructure, and growing demand for pharmaceutical products; and for Middle East & Africa, growing investments in the healthcare sector, rising demand for endotoxin testing and removal services, and improving infrastructure.